Preliminary Study of Feasibility of Arthrodesis Scapula-humeral Under Arthroscopy

Not Applicable

Terminated

• Conditions: Arthroscopy Arthrodesis Gleno-humeral
• Interventions: Procedure: arthroscopy arthrodesis of the shoulder

• Registration Number: NCT02566382
• Lead Sponsor: University Hospital, Brest

Brief Summary

Arthrodesis shoulder blade/humerus under arthroscopy. Implementation of an external fixative spray at the proximal level in the thorn of the scapula and distal in the diaphysis humerus.

Detailed Description

This trial is about the arthrodesis shoulder blade/humerus under arthroscopy. The main aim of this study is to be able to carry out a fusion scapula-humeral supplements in 6 months. It is required to provide the benefice risk over to reduce the hospitalisation 48 hours.

Study Timeline

• Study Start: 2015-09
• Study First Submitted: 2015-09-29
• Study First Submitted QC: 2015-10-01
• Study First Posted: 2015-10-02
• Status Verified: 2017-10
• Primary Completion: 2017-10
• Study Completion: 2017-10
• Last Update Submitted: 2017-10-18
• Last Update Posted: 2017-10-19

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

• Patient having a deficit scapula-humeral mobility
• Impossibility of being operated for a preserving nervous surgery
• Patient affiliation with a social security
• Patient who signed inform consent

Exclusion Criteria

• Patient with No mobility in all the articulations of the shoulder
• Callus malunion of the higher end of the humerus or the glen of the scapula
• Unable to sign an inform consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
shoulder arthroscopy arthrodesis	arthroscopy arthrodesis of the shoulder	The shoulder surgery will be realized under arthroscopy only.

Primary Outcome Measures

Name	Time	Method
Radiological fusion gleno humeral on side and front view after the 6th month of the arthroscopy interventional	6 months	This outcome will be considered like a success if the investigators get a continuous bone matrix between the humeral head and glenoid on the scapula and bone frame continues between the humeral head and the acromion. This evaluation will be done by radiographies.

Secondary Outcome Measures

Name	Time	Method
Blood loss	3 days	The blood loss during and after the surgery will be calculated and will be considered like a success if the total blood loss are less than 600ml.

Trial Locations

Locations (1)

Brest university hospital; 🇫🇷 Brest, Bretagne, France